There are three types of myeloproliferative neoplasms, all of which come with their own set of symptoms and management strategies. Understanding which of the three types of myeloproliferative ...
INCA033989 targets CALR mutations, showing efficacy in engineered cell lines and mouse models of MPNs, without affecting other cells. CALR mutations are significant in JAK2V617F-negative essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback